Quantitative Synthesis of Factors Associated with COVID-19 Vaccine Acceptance and Vaccine Hesitancy in 185 Countries

被引:5
|
作者
Dinga, Jerome Nyhalah [1 ,2 ]
Kabakama, Severin [3 ]
Njimoh, Dieudonne Lemuh [4 ]
Chia, Julius Ebua [5 ]
Morhason-Bello, Imran [6 ]
Lumu, Ivan [7 ]
机构
[1] Michael Gahnyam Gbeugvat Fdn, POB 63, Buea, Cameroon
[2] Univ Buea, Biotechnol Unit, POB 63, Buea, Cameroon
[3] Humanitarian & Publ Hlth Consultant, POB 511, Mwanza, Tanzania
[4] Univ Buea, Dept Biochem & Mol Biol, POB 63, Buea, Cameroon
[5] WHO, Reg Off Afr, POB 06, Brazzaville, Rep Congo
[6] Univ Ibadan, Coll Med, Ibadan 200284, Nigeria
[7] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, POB 7072, Kampala, Uganda
关键词
COVID-19; health belief model; vaccine acceptance; vaccine hesitancy; gross domestic product; quantitative synthesis; world bank income level; meta-analysis; HEALTH-CARE WORKERS; SARS-COV-2; TURKEY; WOMEN;
D O I
10.3390/vaccines12010034
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mass vaccination against COVID-19 is the best method to ensure herd immunity in order to curb the effect of the pandemic on the global economy. It is therefore important to assess the determinants of COVID-19 vaccine acceptance and hesitancy on a global scale. Factors were recorded from cross-sectional studies analyzed with t-Test, ANOVA, correlation, and meta-regression analyses and synthesized to identify global trends in order to inform policy. We registered the protocol (ID: CRD42022350418) and used standard Cochrane methods and PRISMA guidelines to collect and synthesize cross-sectional articles published between January 2020 and August 2023. A total of 67 articles with 576 studies from 185 countries involving 3081,766 participants were included in this synthesis. Global COVID-19 vaccine acceptance was 65.27% (95% CI; 62.72-67.84%), while global vaccine hesitancy stood at 32.1% (95% CI; 29.05-35.17%). One-Way ANOVA showed that there was no significant difference in the percentage Gross Domestic Product spent on vaccine procurement across the World Bank income levels (p < 0.187). There was a significant difference of vaccine acceptance (p < 0.001) and vaccine hesitancy (p < 0.005) across the different World Bank Income levels. World Bank income level had a strong influence on COVID-19 vaccine acceptance (p < 0.0004) and hesitancy (p < 0.003) but percentage Gross Domestic Product spent on vaccine procurement did not. There was no correlation between percentage Gross Domestic Product spent on vaccine procurement and COVID-19 vaccine acceptance (r = -0.11, p < 0.164) or vaccine hesitancy (r = -0.09, p < 0.234). Meta-regression analysis showed that living in an urban setting (OR = 4.83, 95% CI; 0.67-212.8), rural setting (OR = 2.53, 95% CI; 0.29-119.33), older (OR = 1.98, 95% CI; 0.99-4.07), higher education (OR = 1.76, 95% CI; 0.85-3.81), and being a low income earner (OR = 2.85, 95% CI; 0.45-30.63) increased the odds of high COVID-19 vaccine acceptance. Factors that increased the odds of high COVID-19 vaccine hesitancy were no influenza vaccine (OR = 33.06, 95% CI; 5.03-1395.01), mistrust for vaccines (OR = 3.91, 95% CI; 1.92-8.24), complacency (OR = 2.86, 95% CI; 1.02-8.83), pregnancy (OR = 2.3, 95% CI; 0.12-141.76), taking traditional herbs (OR = 2.15, 95% CI; 0.52-10.42), being female (OR = 1.53, 95% CI; 0.78-3.01), and safety concerns (OR = 1.29, 95% CI; 0.67-2.51). We proposed a number of recommendations to increase vaccine acceptance and ensure global herd immunity against COVID-19.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] COVID-19 Vaccine Acceptance in Pregnancy
    Odedokun, Temitope
    Marquez, Rafael
    Thakkar, Meera
    Dinglas, Cheryl
    El Kady, Dina
    AMERICAN JOURNAL OF PERINATOLOGY, 2024, 41 : e617 - e622
  • [42] The Rationality of COVID-19 Vaccine Hesitancy
    Kelsall, Joshua
    EPISTEME-A JOURNAL OF INDIVIDUAL AND SOCIAL EPISTEMOLOGY, 2023,
  • [43] COVID-19 vaccine hesitancy and gender
    Walcherberger, Christina
    Eberl, Jakob-Moritz
    Partheymueller, Julia
    Paul, Katharina T.
    Stamm, Tanja A.
    EUROPEAN JOURNAL OF POLITICS AND GENDER, 2022, 5 (02): : 270 - 274
  • [44] Vaccine hesitancy in the era of COVID-19
    Troiano, G.
    Nardi, A.
    PUBLIC HEALTH, 2021, 194 : 245 - 251
  • [45] Psychological factors affecting COVID-19 vaccine acceptance in Indonesia
    Yanto, Theo Audi
    Octavius, Gilbert Sterling
    Heriyanto, Rivaldo Steven
    Ienawi, Catherine
    Nisa, Haviza
    Pasai, H. Emildan
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2021, 57 (01)
  • [46] Understanding vaccine hesitancy in COVID-19
    Trogen, Brit
    Pirofski, Liise-anne
    MED, 2021, 2 (05): : 498 - 501
  • [47] Do we trust the government? Attributes of COVID-19 vaccine hesitancy and acceptance in Nigeria
    Ekwebelem, Osmond C.
    Onyeaka, Helen
    Yunusa, Ismaeel
    Miri, Taghi
    Onwuneme, Yahwedalu M.
    Eunice, Ayeni T.
    Anyogu, Amara
    Obi, Bright
    Carol, Ngwogu Ada
    AIMS MEDICAL SCIENCE, 2022, 9 (02): : 268 - 282
  • [48] Spatial multilevel analysis of individual, household, and community factors associated with COVID-19 vaccine hesitancy in the Dominican Republic
    Behzad Kiani
    Benn Sartorius
    Beatris Mario Martin
    Angela Cadavid Restrepo
    Helen J. Mayfield
    Cecilia Then Paulino
    Petr Jarolim
    Micheal De St Aubin
    Ronald Skews Ramm
    Devan Dumas
    Salome Garnier
    Marie Caroline Etienne
    Farah Peña
    Gabriela Abdalla
    Adam Kucharski
    William Duke
    Margaret Baldwin
    Bernarda Henríquez
    Lucia de la Cruz
    Eric J. Nilles
    Colleen L. Lau
    Scientific Reports, 15 (1)
  • [49] Understanding the COVID-19 vaccine uptake, acceptance, and hesitancy in Ethiopia and Tanzania: a scoping review
    Gudina, Esayas Kebede
    Muro, Florida Joseph
    Kyala, Norman Jonas
    Melaku, Tsegaye
    Sorensen, Jane Brandt
    Meyrowitsch, Dan Wolf
    Mekonnen, Zeleke
    Draebel, Tania Aase
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [50] COVID-19 Vaccine Hesitancy and Its Associated Factors Among Adolescents
    Alemu, Dawit
    Diribsa, Tujuba
    Debelew, Gurmesa Tura
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 1271 - 1280